Lv52
934 积分 2025-08-24 加入
Lilly’s tirzepatide and Novo Nordisk’s semaglutide vie for top drug spot
17天前
已关闭
The Kidney in Obesity: Current Evidence, Perspectives and Controversies
20天前
已完结
Discovery of GLP-1–Based Drugs for the Treatment of Obesity
20天前
已完结
GLP-1-based therapies for diabetes, obesity and beyond
20天前
已完结
Tirzepatide for Obesity Treatment and Diabetes Prevention
20天前
已完结
Obesity in Adolescents
20天前
已完结
Obesity in adults
20天前
已完结
Definition and diagnostic criteria of clinical obesity
20天前
已完结
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
20天前
已完结
Donanemab in Early Symptomatic Alzheimer Disease
1个月前
已完结
皖公网安备34019202002308
